Search 

Luisa has been developing international teams for the last ten years and has been responsible for rolling out business-models in different sectors. Prior to that, she studied languages in Seville (ES), Bogotá (COL) and Mainz (GER). After finishing her studies, she worked for four years as Client Care Manager in Istanbul, Dubai and Johannesburg. Being based in Turkey, Luisa implemented the company’s European structure to the entire CEMEA area, while reporting to the HQ in Paris. For the last four years, she has been working as Senior Manager Business Development for the secure-cloud-provider Drooms and has been building up the life-science sector ever since.

Dr. Laurent Audoly is Senior Vice President and heads Research and Development at Fabre Pharmaceuticals for both novel medicines and consumer healthcare products. Laurent is also Managing Partner and Founder of the Pierre Fabre Fund for Innovation. In addition, Laurent is president of the Orphan Diseases and the Medical Devices units within Pierre Fabre.
Prior to this role, Laurent was Chief Scientific Officer in biotech focused on next generation therapeutic proteins where he led the growth of the pipeline from no drug candidates prior to his arrival to a high value pipeline and multiple strategic partnerships with big pharma ultimately leading to a successful exit.
Laurent has held positions of increasing leadership responsibilities in the pharmaceutical industry (Pfizer, Merck, MedImmune) contributing to the identification of new projects and the development of five approved drugs in inflammation, dermatology, cardiovascular diseases, and oncology as well as leading large teams across the pharma value chain.
Throughout his career, he has championed high impact collaborations and established a world-wide network of academic and company-based partnerships. Many of these collaborations have resulted in drug development projects. Laurent is focused on strategic and business growth and has also established strong connections with internal and external commercial and manufacturing organizations. He studied medicine and chemistry for his Bachelor’s degree and graduated with a Ph.D. in Pharmacology from Vanderbilt University. Laurent was awarded a fellowship from the American Heart Association during his post-doctoral training at Duke University. Laurent has maintained strong ties with the academic world as an Associate Professor (Adj) at Duke NUS Graduate Medical School. He has also served on NIH study sections, given seminars at universities across the world, and published > 70 papers and patents. He is on the board and an advisor for multiple healthcare organizations across the world aimed at improving healthcare and accelerating the discovery and advancement of novel therapies for patients and their families.

A CEO of major international biotech companies, as well as co-founder and shareholder of ABIVAX. An optimization expert in innovation cycle, from the early identification of molecules with a high potential for value creation who could benefit patients and shareholders in the long term, to their final release on the international market. A business valuation specialist of companies who hold a portfolio of innovative products, through their listing on a stock market or following their potential takeover. Executive partner of the Pierre Fabre Fund for Innovations.